RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > China: 2011 Adverse Reaction Report Released

China: 2011 Adverse Reaction Report Released

Posted 01 June 2012 | By Louise Zornoza

China's State Food and Drug Administration (SFDA) has released a report detailing the adverse event reports it received during 2011. The report notes events involving anti-infective medicines accounted for the higher number of reports, including cephalosporins (34.8%), penicillin (14%) and quinolones (12.2%).

New and serious adverse drug reactions accounted for 17.1% of the total number of reports.  Medical institutions were the primary source for such reports, accounting for about 83% of all reported events.

Read more:

2011 adverse reactions report

More Breaking News from RegLink


© 2022 Regulatory Affairs Professionals Society.